UPDATE: BTIG Initiates Coverage On Pharmacyclics

By: via Benzinga
BTIG initiated coverage on Pharmacyclics, Inc. (NASDAQ: PCYC) Monday with a Buy rating and $225 price target. Analyst Hartaj ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.